Omeros Corporation

OMER NASDAQ Santé & Biotech États-Unis US6821431029
10.28 $
6.64 %

Omeros Corporation développe et commercialise des médicaments pour traiter les troubles et les maladies inflammatoires ou immuno-pathologiques.

Performance & Momentum

6 Months 0.42 %
1 Year 200.31 %
3 Years 53.26 %
5 Years 31.74 %

Similar stocks to Omeros Corporation

Anantys Community

Be the first to share your analysis on Omeros Corporation.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases